Hsin-Ta Wu

2.4k total citations
15 papers, 177 citations indexed

About

Hsin-Ta Wu is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Hsin-Ta Wu has authored 15 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 10 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Hsin-Ta Wu's work include Cancer Genomics and Diagnostics (12 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Cells and Metastasis (5 papers). Hsin-Ta Wu is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Genetic factors in colorectal cancer (7 papers) and Cancer Cells and Metastasis (5 papers). Hsin-Ta Wu collaborates with scholars based in United States, Italy and United Kingdom. Hsin-Ta Wu's co-authors include Himanshu Sethi, Mustafa Balcioglu, Alexey Aleshin, Melinda L. Telli, Anosheh Afghahi, Vasily N. Aushev, Joshua J. Gruber, Alex McMillan, James M. Ford and Kirsten M. Timms and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Hsin-Ta Wu

15 papers receiving 175 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hsin-Ta Wu United States 7 112 104 68 54 36 15 177
Yannick Boursin France 6 69 0.6× 67 0.6× 75 1.1× 35 0.6× 29 0.8× 9 190
Guangnan Wei China 6 127 1.1× 97 0.9× 71 1.0× 59 1.1× 23 0.6× 11 209
Jean‐Christophe Théry France 6 129 1.2× 94 0.9× 48 0.7× 69 1.3× 17 0.5× 10 184
Rhiannon Maudsley United Kingdom 5 96 0.9× 101 1.0× 40 0.6× 85 1.6× 20 0.6× 7 152
Ruth M. O'Regan United States 3 100 0.9× 92 0.9× 35 0.5× 40 0.7× 34 0.9× 4 158
Christoph Suppan Austria 9 151 1.3× 142 1.4× 80 1.2× 48 0.9× 29 0.8× 32 241
Rongzhen Luo China 8 70 0.6× 95 0.9× 102 1.5× 44 0.8× 35 1.0× 11 218
M. Kandel Germany 5 94 0.8× 75 0.7× 31 0.5× 32 0.6× 35 1.0× 5 184
Akane Naruoka Japan 8 88 0.8× 96 0.9× 41 0.6× 63 1.2× 66 1.8× 20 190
Kathleen Klein Oros Canada 6 63 0.6× 67 0.6× 111 1.6× 59 1.1× 27 0.8× 8 195

Countries citing papers authored by Hsin-Ta Wu

Since Specialization
Citations

This map shows the geographic impact of Hsin-Ta Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsin-Ta Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsin-Ta Wu more than expected).

Fields of papers citing papers by Hsin-Ta Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsin-Ta Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsin-Ta Wu. The network helps show where Hsin-Ta Wu may publish in the future.

Co-authorship network of co-authors of Hsin-Ta Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Hsin-Ta Wu. A scholar is included among the top collaborators of Hsin-Ta Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hsin-Ta Wu. Hsin-Ta Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Correa, Andres, Ekaterina Kalashnikova, Hsin-Ta Wu, et al.. (2024). Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinoma. The Oncologist. 29(10). 887–893. 9 indexed citations
2.
Alexander, Angela, Vicente Valero, Wendy A. Woodward, et al.. (2023). ctDNA detection before and during systemic therapy for inflammatory breast cancer.. Journal of Clinical Oncology. 41(16_suppl). e12523–e12523. 1 indexed citations
3.
Agostinetto, Elisa, Matteo Lambertini, Françoise Rothé, et al.. (2022). Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse. JCO Precision Oncology. 6(6). e2200148–e2200148. 48 indexed citations
4.
Gruber, Joshua J., Anosheh Afghahi, Kirsten M. Timms, et al.. (2022). A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. Nature Cancer. 3(10). 1181–1191. 67 indexed citations
5.
Young, Amanda, Halla Nimeiri, Russell W. Madison, et al.. (2022). Molecular residual disease (MRD) detection with a tissue comprehensive genomic profiling (CGP)-informed personalized monitoring assay: An exploratory analysis of the IMvigor-010 observation arm.. Journal of Clinical Oncology. 40(6_suppl). 448–448. 3 indexed citations
7.
García-Murillas, Isaac, Rosalind Cutts, Matthew Beaney, et al.. (2022). Abstract P2-01-10: Detection of ctDNA following surgery predicts relapse in breast cancer patients receiving primary surgery. Cancer Research. 82(4_Supplement). P2–1. 2 indexed citations
9.
Agostinetto, Elisa, Matteo Lambertini, Françoise Rothé, et al.. (2022). Abstract P2-01-06: Detection of circulating tumor DNA post neoadjuvant chemotherapy using a personalized assay is associated with disease relapse. Cancer Research. 82(4_Supplement). P2–1. 1 indexed citations
10.
Molinero, Luciana, Derrick Renner, Hsin-Ta Wu, et al.. (2022). Abstract 2796: ctDNA prognosis in adjuvant triple-negative breast cancer. Cancer Research. 82(12_Supplement). 2796–2796. 2 indexed citations
11.
Cheng, Yi-Sung, Nien‐Te Kuo, Kuo‐Chien Chang, & Hsin-Ta Wu. (2021). Using Data Mining Methods to Predict Repeat Patronage Intention in the Restaurant Industry. Journal of Quality Assurance in Hospitality & Tourism. 23(6). 1548–1574. 6 indexed citations
12.
Wu, Hsin-Ta, Ekaterina Kalashnikova, Raheleh Salari, et al.. (2020). Characterization of clonal hematopoiesis of indeterminate potential mutations from germline whole exome sequencing data.. Journal of Clinical Oncology. 38(15_suppl). 1525–1525. 4 indexed citations
13.
Iafolla, Marco, Cindy Yang, Scott Dashner, et al.. (2019). Bespoke circulating tumor DNA (ctDNA) analysis as a predictive biomarker in solid tumor patients (pts) treated with single-agent pembrolizumab (P).. Journal of Clinical Oncology. 37(15_suppl). 2542–2542. 7 indexed citations
14.
Reinert, Thomas, Tenna Vesterman Henriksen, Mads H. Rasmussen, et al.. (2018). Abstract 1590: Personalized circulating tumor DNA analysis to monitor colorectal cancer. Cancer Research. 78(13_Supplement). 1590–1590. 2 indexed citations
15.
Wu, Hsin-Ta, et al.. (2004). Parameter studies and verifications on three-dimensional finite element analysis of rigid pavements. Canadian Journal of Civil Engineering. 31(5). 782–796. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026